NIH-Funded Multidisciplinary Studies Offer Chances For Integrative Research, Mentoring

Ongoing discussions of funding priorities and mechanisms for the National Institutes of Health in the press and among investigators have focused on several critical issues, such as increasing or decreasing funding for established research areas, improving the peer-review process, introducing grant mechanisms to foster young investigators, and developing strategies to identify and support productive new research opportunities. Indeed, efforts to address these and other issues at NIH (the major s

Written byJohn Trojanowski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Ongoing discussions of funding priorities and mechanisms for the National Institutes of Health in the press and among investigators have focused on several critical issues, such as increasing or decreasing funding for established research areas, improving the peer-review process, introducing grant mechanisms to foster young investigators, and developing strategies to identify and support productive new research opportunities. Indeed, efforts to address these and other issues at NIH (the major source of extramural support for biomedical research) are moving forward with promising results under the leadership of NIH Director Harold Varmus.

Discussions of funding mechanisms such as multicomponent, multidisciplinary grants that support centers and program projects have drawn less attention, but they have compelling strengths that may not be appreciated by many investigators who are not directly familiar with how these mechanisms work. Most of today's biological problems require multidisciplinary research strategies that entail the use of multiple, diverse methodologies that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies